IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

LAZZARIN, ADRIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.359
AS - Asia 4.171
NA - Nord America 3.977
SA - Sud America 398
AF - Africa 136
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 4
Totale 14.064
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.790
GB - Regno Unito 2.020
CN - Cina 1.224
SG - Singapore 1.195
IT - Italia 796
DE - Germania 763
VN - Vietnam 499
SE - Svezia 394
RU - Federazione Russa 391
HK - Hong Kong 365
BR - Brasile 300
FR - Francia 203
TR - Turchia 195
IE - Irlanda 180
NL - Olanda 167
KR - Corea 161
IN - India 154
CA - Canada 153
BD - Bangladesh 136
FI - Finlandia 124
UA - Ucraina 99
EU - Europa 60
TW - Taiwan 40
ID - Indonesia 38
GR - Grecia 37
JP - Giappone 35
CI - Costa d'Avorio 30
DK - Danimarca 29
AR - Argentina 25
ES - Italia 25
PL - Polonia 25
ZA - Sudafrica 25
IQ - Iraq 24
CO - Colombia 23
BE - Belgio 19
CH - Svizzera 19
CL - Cile 19
AU - Australia 18
MX - Messico 18
PK - Pakistan 15
NO - Norvegia 12
PH - Filippine 12
RO - Romania 12
AT - Austria 11
MA - Marocco 11
SA - Arabia Saudita 11
AE - Emirati Arabi Uniti 10
MY - Malesia 9
TN - Tunisia 9
EC - Ecuador 8
KE - Kenya 8
TH - Thailandia 7
TZ - Tanzania 7
UZ - Uzbekistan 7
VE - Venezuela 7
AZ - Azerbaigian 6
BG - Bulgaria 6
GH - Ghana 6
UY - Uruguay 6
KZ - Kazakistan 5
MK - Macedonia 5
PT - Portogallo 5
UG - Uganda 5
BO - Bolivia 4
CZ - Repubblica Ceca 4
EG - Egitto 4
ET - Etiopia 4
IR - Iran 4
NG - Nigeria 4
NP - Nepal 4
SL - Sierra Leone 4
AO - Angola 3
JM - Giamaica 3
LT - Lituania 3
MD - Moldavia 3
PA - Panama 3
PE - Perù 3
PY - Paraguay 3
SC - Seychelles 3
ZW - Zimbabwe 3
CR - Costa Rica 2
CY - Cipro 2
DZ - Algeria 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
JO - Giordania 2
KG - Kirghizistan 2
LB - Libano 2
MW - Malawi 2
OM - Oman 2
ZM - Zambia 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BW - Botswana 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GM - Gambi 1
Totale 14.109
Salva come PNG Salva come JPEG
Città #
Southend 1.891
Singapore 683
Frankfurt am Main 510
Ashburn 385
Hong Kong 337
Chandler 328
Milan 269
San Jose 242
Dallas 205
Seattle 202
Beijing 200
Dublin 179
Princeton 178
Wilmington 151
Ho Chi Minh City 134
Redmond 131
Council Bluffs 121
Los Angeles 104
Toronto 99
Santa Clara 96
Fairfield 95
Hanoi 91
Ann Arbor 89
Lauterbourg 83
Nanjing 81
New York 80
Guangzhou 70
Bengaluru 64
Dearborn 61
Des Moines 59
Woodbridge 54
Rome 53
Sakarya 53
Boardman 52
Buffalo 52
Dong Ket 52
Helsinki 49
Andover 47
Moscow 45
Jinan 42
Mountain View 42
Seoul 38
Houston 37
The Dalles 36
Jacksonville 35
Shanghai 35
Columbus 34
Shenyang 34
Grafing 33
Abidjan 30
Da Nang 30
Zhengzhou 30
Changsha 27
Cambridge 26
Munich 25
Pisa 25
Tokyo 25
Hefei 24
São Paulo 24
Berlin 23
Cangzhou 23
Jakarta 23
Phoenix 22
Somerville 22
Haiphong 21
Hanover 21
Redwood City 20
Tianjin 20
Jiaxing 19
Nuremberg 19
Bogotá 18
Eitensheim 17
Falls Church 17
Ottawa 17
San Diego 17
Athens 16
Hangzhou 16
Hebei 16
London 16
Shenzhen 16
Warsaw 16
Brussels 15
Nanchang 15
Serra 15
Zhongli District 15
Atlanta 14
Baghdad 14
Kent 14
Ningbo 14
Daejeon 13
Mumbai 13
Bitonto 12
Istanbul 12
Turku 12
Bologna 11
Piscataway 11
Santiago 11
Bühl 10
Chicago 10
Lanzhou 10
Totale 8.963
Salva come PNG Salva come JPEG
Nome #
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline VIRO-immunological status and outcome in patients under first-line ART 577
Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per μl in Europe and North America: A pooled cohort observational study 481
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004–2014 314
Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2011 282
Virological response and retention in care according to time of starting ART in Italy: Data from the Icona Foundation Study cohort 281
Burden of Disease in PWH Harboring a Multidrug-Resistant Virus: Data from the PRESTIGIO Registry 266
Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons : update 2016 235
The presence of anti-Tat antibodies in HIV-infected individuals is associated with containment of CD4+ T-cell decay and viral load, and with delay of disease progression: Results of a 3-year cohort study 232
Studio della funzionalità granulocitaria in pazienti in fase acuta di malattia grave 231
Managing the long surviving HIV patient : a proposal for a multidimensional first-level diagnostic assessment 230
Aumento della concentrazione liquorale di leucotriene B4 in pazienti con AIDS 224
Significant link between sCD30 changes and HIV viremia in patients treated with HAART 223
Polymorphonuclear leukocyte function in burned patients : effect of isoprinosine 221
Evaluation of HIV-DNA and residual viremia levels through week 96 in HIV-infected individuals who continue a two-drug or switch to a three-drug integrase strand transfer inhibitor-based regimen 217
Hemophilia and nonprogressing human immunodeficiency virus type 1 infection 217
The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort 212
HIV-1 Tat immunization restores immune homeostasis and attacks the HAART-resistant blood HIV DNA : Results of a randomized phase II exploratory clinical trial 211
Key questions in antiretroviral therapy : Italian Consensus Workshop (2005) 209
Soluble endothelial protein C receptor (sEPCR) as an inflammatory biomarker in naive HIV-infected patients during ART 209
Polymorphonuclear leucocyte function during acute viral hepatitis 206
Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2) : week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials 203
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection? 198
Hepatitis C virus (HCV) coinfection in a cohort of HIV positive long-term non-progressors : possible protective effect of infecting HCV genotype on HIV disease progression 190
Selective granulocyte/monocyte apheresis in the treatment of HIV-infected patients : short-term and long-term effects on immunological and virological parameters 183
Outbreak of persistent, unexplained, generalized lymphadenopathy with immunological abnormalities in drug addicts in Milan 180
Gender differences in antiretroviral drug-related adipose tissue alterations. Women are at higher risk than men and develop particular lipodystrophy patterns 176
Long-term efficacy of dolutegravir in treatment-experienced subjects failing therapy with HIV-1 integrase strand inhibitor-resistant virus 176
Population pharmacokinetics and pharmacogenetics of ritonavir-boosted darunavir in the presence of raltegravir or tenofovir disoproxil fumarate/emtricitabine in HIV-infected adults and the relationship with virological response : a sub-study of the NEAT001/ANRS143 randomized trial 174
Brachial paresis complicating acute non-A, non-B hepatitis 172
Risk of clinical events in virologically suppressed people with HIV switching to a two-drug regimen vs. remaining on a three-drug regimen: a target trial emulation 171
Switching to unboosted atazanavir improves glucose tolerance in highly pretreated HIV-1 infected subjects 170
Shorter survival of SDF1-3'A/3'A homozygotes linked to CD4+ T cell decrease in advanced human immunodeficiency virus type 1 infection 169
Immunological status in heroin addicts: effects of methadone maintenance treatment 167
Occurrence of hepatocellular carcinoma in HIV/HCV co-infected patients treated with direct-acting antivirals 165
Recombinant human growth hormone : rationale for use in the treatment of HIV-associated lipodystrophy 164
48 week outcomes of maraviroc-containing regimens following the genotypic or Trofile assay in HIV-1 failing subjects: the OSCAR Study 164
Potential associations between atazanavir exposure and clinical outcome: a pharmacokinetic sub-study from the MODAt randomized trial 164
Benefits of a 12 week physical activity programme on muscle and bone health in people living with HIV 164
[Generalized and persistent lymphadenopathy in drug addicts: clinical and epidemiological aspects] 160
Effect of ambroxol on human phagocytic cell function 155
Effetto dell’ambroxol sull’attività delle cellule fagocitiche “in vitro” 155
Inosiplex in recurrent herpes simplex infections 154
Host and disease factors are associated with cognitive function in European HIV-infected adults prior to initiation of antiretroviral therapy 154
Chronic Granulomatous Disease 153
Humoral immune responses in human loaiasis 152
Disseminated Aspergillosis 149
A Mobile Application for Exercise Intervention in People Living with HIV 148
Attempt to treat acute type B hepatitis with an orally administered thymic extract (thymomodulin): preliminary results 147
Attempted treatment of fulminant viral hepatitis with human fibroblast interferon 143
Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial : Raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART 143
GH treatment reduces trunkal adiposity in HIV-infected patients with lipodystrophy : a randomized placebo-controlled study 142
Pulmonary candidiasis in a heroin addict: some remarks on its aetiology and pathogenesis 142
Epidemic of LAV/HTLV III infection in drug addicts in Milan: serological survey and clinical follow-up 141
Clinical and immunological aspects of HIV infection in drug addicts 140
ABC of AIDS: treatment of infections and antiviral agents 138
A study of cellular immunity in newborns after prevention of respiratory distress syndrome (RDS) 137
Decreased chloroquine sensitivity of Plasmodium falciparum in two Italian travellers from Madagascar 137
Defect of leukocyte functions and circulating immune complexes in visceral leishmaniasis 134
Structural skull defects in type IV Ehlers-Danlos syndrome 134
Thymostimulin treatment in AIDS-related complex 133
Monocyte-derived macrophage function in HIV-infected subjects. In vitro modulation by rIFN-gamma and rGM-CSF. 133
Fc receptors expression and function in mononuclear phagocytes from AIDS patients: modulation by IFN-gamma 133
Lymph node finding in drug abusers 130
Evidence-based renewal of the Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons 130
AIDS, zinc deficiency, and thymic hormone failure 128
Milan as possible starting point of LAV/HTLV III epidemic among Italian drug addicts 127
Granulocyte/monocyte apheresis induces sustained increases in CD4 T cells in HIV-1 infected patients with poor CD4 T cell restoration after suppression of viral replication by HAART 126
HIV-1 and HIV-2 infections in Italian AIDS/ARC patients 126
Long-term treatment with zidovudine in patients with human immunodeficiency virus (HIV)-associated thrombocytopenia : modes of response and correlation with markers of HIV replication 123
Anti HLA antibodies associated with resistance to HIV infection 122
[Transitory increase of OKT4+ lymphocytes in the peripheral blood of patients with lymphadenopathy syndrome treated with beta-interferon] 115
Infection-related and -unrelated malignancies, HIV and the aging population 114
HIV-related severe thrombocytopenia in intravenous drug users: prevalence, response to therapy in a medium-term follow-up, and pathogenetic evaluation 112
Systemic inflammation markers after simplification to atazanavir/ritonavir plus lamivudine in virologically suppressed HIV-1-infected patients : ATLAS-M substudy 112
Monocyte function in intravenous drug abusers with lymphadenopathy syndrome and in patients with acquired immunodeficiency syndrome: selective impairment of chemotaxis 110
HIV-1 recombinant forms in immigrants regularly residing in Milan, northern Italy 110
Stavudine or indinavir-containing regimens are associated with an increased risk of diabetes mellitus in HIV-infected individuals 104
Establishing a hepatitis C continuum of care among HIV/hepatitis C virus-coinfected individuals in EuroSIDA 103
Liver-related death among HIV/hepatitis C virus-co-infected individuals : implications for the era of directly acting antivirals 102
Membrane expression and function of complement receptors CR1 and CR3 on neutrophils from HIV-infected subjects: modulation by rTNF- and rGM-CSF. 100
SARS-CoV-2 IgG/IgM Rapid Test as a Diagnostic Tool in Hospitalized Patients and Healthcare Workers, at a large Teaching Hospital in northern Italy, during the 2020 COVID-19 Pandemic 100
Prevention of symptomatic recurrences of esophageal candidiasis in AIDS patients after the first episode: a prospective study 99
Recommendations for the management of pulmonary fungal infections in patients with rheumatoid arthritis 98
Immunovirological improvement in partially HAART responder HIV-infected patients by monocyte adsorption apheresis 89
Impairment of polymorphonuclear leucocyte function in patients with acquired immunodeficiency syndrome and with lymphadenopathy syndrome 89
Increase of OKT4+ cells during treatment with thymostimulin in parenteral drug addicts with persistent generalized lymphadenopathy 86
Neurological symptoms during primary human immunodeficiency virus (HIV) infection correlate with high levels of HIV RNA in cerebrospinal fluid 80
Severe abdominal pain in patients with AIDS: Frequency, clinical aspects, causes, and outcome 73
Evolution of blood-associated HIV-1 DNA levels after 48 weeks of switching to atazanavir/ritonavir+lamivudine dual therapy versus continuing triple therapy in the randomized AtLaS-M trial 58
null 1
Totale 14.752
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.178
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.178
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021301 0 0 0 0 0 0 0 0 0 0 199 102
2021/20221.043 92 46 23 66 77 59 98 89 146 80 98 169
2022/20231.254 147 120 115 130 139 227 29 74 171 16 58 28
2023/20241.067 21 59 47 47 198 83 100 90 38 105 139 140
2024/20252.058 122 214 89 241 116 82 72 188 138 191 177 428
2025/20263.973 351 215 437 301 400 346 700 215 383 289 336 0
Totale 14.752